DOCSLIB.ORG

Chapter 7. Interventions to Reduce Maternal and Child Morbidity and Mortality

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chapter 7. Interventions to Reduce Maternal and Child Morbidity and Mortality Chapter 7. Interventions to Reduce Maternal and Child Morbidity and Mortality A. Metin Gülmezoglu1, Theresa Lawrie1, Natasha Hezelgrave2, Olufemi Oladapo1, João Paulo Souza3, Marijke Gielen4, Joy Lawn5, Rajiv Bahl1, Fernando Althabe6, Agustina Mazzoni6, and G. Justus Hofmeyr7 1UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, 1201 Geneva, Switzerland. 2 Division of Women's Health, King's College London School of Medicine, London, UK. 3 Department of Social Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Brazil. 4 5 Maternal, Adolescent Reproductive and Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK; Saving Newborn Lives, Save the Children, Washington, DC, USA; Research and Evidence Division, UK AID, London, UK. 6 Institute for Clinical Effectiveness and Health Policy (IECS), Dr. Emilio Ravignani 2024, C1414CPV, Buenos Aires, Argentina. 7 Effective Care Research Unit, East London Hospital Complex, East London, South Africa Boxes: 1 Figures: 1 Tables: 4 1 | P a g e Outline I. Introduction II. Interventions to Reduce Maternal Mortality and Morbidity A. Postpartum Hemorrhage 1. Preventing PPH 2. Treating PPH B. Preeclampsia and Eclampsia 1. Preventing Preeclampsia and Eclampsia 2. Treating Preelampsia and Eclampsia C. Obstructed Labor 1. Preventing Obstructed Labour 2. Managing Obstructed Labour D. Maternal Sepsis 1. Preventing Maternal Sepsis 2. Treating Maternal Sepsis III. Interventions to Reduce Stillbirths and Newborn Mortality and Morbidity A. Antenatal Interventions 1. Nutritional Interventions 2. Treatment of Maternal Infections 3. Treatment of Hypertensive Disorders 4. Treatment of Diabetes Mellitus and Gestational Diabetes 5. Intrauterine Growth Restriction 6. Postterm Pregnancy B. Intrapartum Interventions 1. General Interventions 2. Preterm Labor and Preterm Pre-Labor Rupture of Membranes 3. Newborn Resuscitation 4. Essential Newborn Care C. Neonatal Interventions 1. Birth Asphyxia 2. Respiratory Distress Syndrome 3. Neonatal Sepsis 4. Pipeline Interventions IV. Cost-effectiveness V. Conclusions 2 | P a g e Introduction In 2010, an estimated 287,000 women died as a result of pregnancy and childbirth-related complications. Most of these deaths occurred in low-income countries (LICs). Sub-Saharan Africa has the highest maternal mortality ratio (MMR), estimated at 500 maternal deaths per 100,000 live births in 2010; by contrast, the MMR for developed regions was estimated at 16 maternal deaths per 100,000 live births (Souza and others 2013). Although significant progress has been made since 1990 toward achieving the MDGs, with a reduction in the global MMR from 400 to 210 maternal deaths per 100,000 live births, much work remains to be done, as this reduction (almost 50 percent) falls short of the 2015 MDG 5 target of 75 percent. Similarly, mortality for children under five years (MDG 4) has declined by 47 percent, from nearly 12.4 million in 1990 to 6.6 million in 2012, short of the 2015 target of 67 percent (Souza and others 2013; UNICEF and WHO 2013). Again, the distribution of the global burden of child mortality is disparate. Within countries when the population is disaggregated by income, education, or place of residence, wide disparities can be shown, even in those areas where the overall mortality seems low. Communicable, maternal, neonatal, and nutritional causes account for 25 percent of deaths and remain dominant causes of premature mortality in Sub-Saharan Africa (Hewitt 1988; Ngoc and others 2006). Newborns account for almost half (44 percent) of all under-five deaths, with this percentage reaching 50 percent or higher in several countries (United Nations 2013). Preterm birth and birth asphyxia account for 21% of under-five child mortality in 2008 (Black and others 2010). 3 | P a g e The tracking of progress in meeting the MDGs does not include declines in the numbers of stillbirths. In 2009, an estimated 2.64 million stillbirths occurred in the last trimester of pregnancy, with more than 45 percent in the intrapartum period (Cousens and others 2011; Lawn and others 2011). The majority of these stillbirths (98 percent) occur in low- and middle-income countries (LMICs) (Black and others 2010). Box 1 Millennium Development Goals 4 and 5 MDG 4: Reduce child mortality Target: 1. Reduce by two thirds, between 1990 and 2015, the under-five mortality rate. MDG 5: Improve maternal Health Targets: 1. Reduce by three quarters, between 1990 and 2015, the maternal mortality ratio 2. Achieve, by 2015, universal Access to reproductive health Significant proportions of these maternal, fetal, and newborn deaths are preventable and underscore the importance of initiatives to meet the Millennium Development Goals (MDG) 4 and 5.This chapter discusses and recommends the implementation of interventions in the context of people’s right to access good quality, respectful, and timely care—wherever they may live. Interventions to Reduce Maternal Mortality and Morbidity Major obstetric causes of maternal mortality include hemorrhage, hypertensive diseases of pregnancy (mainly preeclampsia/eclampsia), sepsis, and obstructed labor. In a cross-sectional study conducted across 29 countries in Asia, Latin America and the Caribbean, the Middle East and North Africa, and Sub- Saharan Africa, postpartum hemorrhage and preeclampsia/eclampsia accounted for 27 percent and 26 percent, respectively, of severe maternal outcomes (Souza and others 2013). Table 7.1 provides an overview of evidence-based effective interventions to reduce poor maternal outcomes. The contribution of indirect causes of maternal deaths, such as medical disorders, malaria, tuberculosis, and HIV seem to be increasing, which raises the importance of integrating service delivery during pregnancy and childbirth. 4 | P a g e Table 7.1 Some Evidence-Based Effective Interventions that Reduce Maternal Morbidity and Mortality Type of Main effects Quality of Source of intervention evidencea evidence Postpartum hemorrhage Oxytocin Halves PPH risk when used High Westhoff, Cotter, routinely and Tolosa 2013 Is well tolerated Is recommended for prevention and treatment Misoprostol Reduces PPH risk and the need for Moderate Tunçalp, blood transfusion Hofmeyr, and Side effects of shivering and fever Gülmezoglu 2012 Recommended for PPH prevention if oxytocin unavailable Preeclampsia and eclampsia Calcium Halves preeclampsia risk in all High Hofmeyr and supplementation women others 2014 Risk reduction is greatest in high risk women and those with low dietary calcium intake Aspirin Reduces the risk of preeclampsia in High Duley and others supplementation high-risk women 2007 Magnesium Reduces the risk of seizures in High Altman and sulphate women with preeclampsia, with a others 2002 trend to reduced maternal mortality Timing of delivery Induction of labour after 36 weeks’ High Koopmans and gestation reduces poor maternal others 2009 outcomes in mild preeclampsia Sepsis Prophylactic Reduces risk of febrile morbidity, High Smaill and Gyte antibiotics at wound infection, endometritis and 2010 cesarean section serious maternal infectious morbidity General interventions Posture in labour Upright and ambulant postures High Lawrence and reduces labor duration and the need others 2013 for cesarean sections Note: a = Based on GRADE Working Group grades of evidence. (Atkins and others 2004) 5 | P a g e Postpartum Hemorrhage Preventing Postpartum Hemorrhage The most effective intervention for preventing postpartum hemorrhage is the use of uterotonics—drugs that contract the uterus—during the third stage of labor when the placenta is delivered. An injectable uterotonic is the drug of choice; however, oral or sublingual misoprostol may be used when injectable uterotonics are not available. Other interventions include uterine massage, cord clamping, and controlled cord traction (table 7.1). Table 7.2 Interventions to Prevent Postpartum Hemorrhage Evidence-Based Effective Interventions for PPH Prevention Uterotonics used during the third stage of labor: Oxytocin (10 IU IM or IV) is the drug of choice. (Westhoff, Cotter, and Tolosa 2013) In settings where oxytocin is unavailable, other injectable uterotonics (ergot alkaloids if appropriate, or the fixed drug combination of oxytocin/ergometrine), or oral misoprostol (600 μg) are recommended. (WHO 2012) Interventions with No Evidence, or Inconclusive Evidence, for PPH Prevention Uterine massage (Hofmeyr, Abdel-Aleem, and Abdel-Aleem 2013) Early vs late cord clamping (McDonald and others 2013) Controlled cord traction (Gülmezoglu and others 2012b; Deneux- Tharaux and others 2013) Uterotonic Agents. Two uterotonic agents used prophylactically are oxytocin and misoprostol. [bullet]Oxytocin and ergot alkaloids. A Cochrane review assessed the effect of prophylactic oxytocin given during the third stage of labor on PPH (blood loss greater than 500 mL) (Westhoff, Cotter, and Tolosa 2013). The review included 20 randomized clinical trials (RCTs) involving 10,806 women. Prophylactic oxytocin, compared with placebo, halved the risk of PPH and, when compared with ergot alkaloids, reduced the risk of PPH by 25 percent.. There was no significant difference in the risk of PPH with the combination of oxytocin/ergometrine versus ergot alkaloids alone. Oxytocin was better tolerated than ergot alkaloids. [bullet]Misoprostol.
Load more

Recommended publications
  • ASSIST II Participant Information Leaflet V2.0 07JUL2020.Pdf
    The BD Odon Device™ for assisted vaginal birth: A feasibility study to investigate safety and efficacy The ASSIST II Study Participant Information Leaflet Would you be willing to join us in a research project? Page 1 of 10 ASSIST II Participant Information Leaflet v2.0 (07JUL2020) The ASSIST II Study: A study investigating the use of a device that may be used to assist a baby’s birth We would like to invite you to join us in a research study investigating a new device which may be used to assist your baby’s birth. Before you decide whether you would like to participate, it is important for you to understand why the research is being performed and what it involves. There is also an ASSIST II Study video – the video and this leaflet contain different information so it is important they are used together. You will then be able to ask any questions and be given time to decide if this study is right for you and your baby. Why have I been invited to take part? All women who are pregnant with one baby and are planning a vaginal birth at either Southmead or Cossham Maternity Unit are invited to take part in this study. If you would like to take part, we would like your agreement in principle before labour, just in case you do need assistance with the birth of your baby later on. Do I have to take part? No. It is entirely up to you whether you agree to take part or not. If you decide not to be involved, your care will not be affected in any way.
    [Show full text]
  • FIGURE 1 in Trained Hands, Operative Vaginal Delivery Can Be An
    FIGURE 1 In trained hands, operative vaginal delivery can be an extremely effective intervention to expedite delivery when nonreassuring fetal testing is noted during the second stage of labor. ILLUSTRATION: KIMBERLY MARTENS FOR OBG MANAGEMENT 38 OBG Management | June 2014 | Vol. 26 No. 6 obgmanagement.com UPDATE OPERATIVE VAGINAL DELIVERY New data confirm that the combination of forceps and vacuum extraction should be avoided and demonstrate that use of midcavity rotational forceps is safe and effective ›› Errol R. Norwitz, MD, PhD Dr. Norwitz is Louis E. Phaneuf Professor of Obstetrics and Gynecology, Tufts University School of Medicine, and Chairman of the Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts. Dr. Norwitz serves on the OBG Management Board of Editors. The author reports no financial relationships relevant to this article. he past year has seen the publica- delivery in the setting of transverse arrest, Ttion of four studies with relevance for namely manual rotation, vacuum rota- clinicians: tion, and rotational forceps • a retrospective cohort study that exam- • another retrospective cohort study that ined the maternal risks of operative vaginal compared maternal morbidity among IN THIS ARTICLE delivery using forceps, vacuum extraction operative vaginal deliveries performed by (FIGURE 1), or a combination of forceps midwives and physician providers in the Why you should learn and vacuum United Kingdom to perform midcavity • a prospective cohort study that investi- • a description of a new technique for instru- rotational deliveries gated the efficacy and safety of three dif- mental vaginal delivery that is low-cost, page 40 ferent techniques for midcavity rotational simple, and easy to perform.
    [Show full text]
  • Gtg-No-20B-Breech-Presentation.Pdf
    Guideline No. 20b December 2006 THE MANAGEMENT OF BREECH PRESENTATION This is the third edition of the guideline originally published in 1999 and revised in 2001 under the same title. 1. Purpose and scope The aim of this guideline is to provide up-to-date information on methods of delivery for women with breech presentation. The scope is confined to decision making regarding the route of delivery and choice of various techniques used during delivery. It does not include antenatal or postnatal care. External cephalic version is the topic of a separate RCOG Green-top Guideline No. 20a: ECV and Reducing the Incidence of Breech Presentation. 2. Background The incidence of breech presentation decreases from about 20% at 28 weeks of gestation to 3–4% at term, as most babies turn spontaneously to the cephalic presentation. This appears to be an active process whereby a normally formed and active baby adopts the position of ‘best fit’ in a normal intrauterine space. Persistent breech presentation may be associated with abnormalities of the baby, the amniotic fluid volume, the placental localisation or the uterus. It may be due to an otherwise insignificant factor such as cornual placental position or it may apparently be due to chance. There is higher perinatal mortality and morbidity with breech than cephalic presentation, due principally to prematurity, congenital malformations and birth asphyxia or trauma.1,2 Caesarean section for breech presentation has been suggested as a way of reducing the associated perinatal problems2,3 and in many countries in Northern Europe and North America caesarean section has become the normal mode of breech delivery.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE Gian Carlo Di Renzo, MD, PhD Professional Address Gian Carlo Di Renzo Professor and Chairman Dept. of Ob/Gyn Director, Centre for Perinatal and Reproductive Medicine Santa Maria della Misericordia University Hospital 06132 San Sisto - Perugia - Italy tel. +39 075 5783829 tel. +39 075 5783231 fax +39 075 5783829 [email protected] Date of birth: 13 June 1951 Place of birth: Verona, Italy Citizenship: Italian 1 Director of Education and Communication & Past General Secretary of FIGO University of Perugia, Perugia, Italy. Prof. Gian Carlo Di Renzo is currently Professor and Chair at the University of Perugia (2004 - ), and Director of the Reproductive and Perinatal Medicine Center (1996 - ) , former Director of the Midwifery School (2004-2016), University of Perugia, in addition to being the Director of the Permanent International and European School of Perinatal and Reproductive Medicine (PREIS) in Florence (2012 - ) . After graduation cum laude at Medical School of the University of Padova (1975) , he was a research fellow at the Universities of Verona, Messina and Modena. After training at CHUV in Lausanne (Switzerland), at UCH in London (UK), at the University of Texas in Dallas (USA), and at the Catholic University in Nijmegen (NL) (1977-1982), he became a senior researcher at the University of Perugia. Since 2004 he is Professor and Chairman of the Department of Obstetrics and Gynecology at the University or Perugia., Chairman of the Midwifery School in the year 2004 to 2016, of the Ob Gyn Resident’s program since 2008 and of the PhD Program in Translational Medicine since 2012. He was general Secretary of the Italian Society of Perinatal Medicine, President of the Italian Society of Ultrasound in Obstetrics and Gynecology, Secretary-Treasurer of the European Association of Perinatal Medicine, President from 2000 to 2002, 2002-2008 Executive Director and Chairman of the Educational Committee, Vice President of the World Association of Perinatal Medicine ( 2007-2013) .
    [Show full text]
  • Chapter 12 Vaginal Breech Delivery
    FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM CHAPTER 12 VAGINAL BREECH DELIVERY Learning Objectives By the end of this chapter, the participant will: 1. List the selection criteria for an anticipated vaginal breech delivery. 2. Recall the appropriate steps and techniques for vaginal breech delivery. 3. Summarize the indications for and describe the procedure of external cephalic version (ECV). Definition When the buttocks or feet of the fetus enter the maternal pelvis before the head, the presentation is termed a breech presentation. Incidence Breech presentation affects 3% to 4% of all pregnant women reaching term; the earlier the gestation the higher the percentage of breech fetuses. Types of Breech Presentations Figure 1 - Frank breech Figure 2 - Complete breech Figure 3 - Footling breech In the frank breech, the legs may be extended against the trunk and the feet lying against the face. When the feet are alongside the buttocks in front of the abdomen, this is referred to as a complete breech. In the footling breech, one or both feet or knees may be prolapsed into the maternal vagina. Significance Breech presentation is associated with an increased frequency of perinatal mortality and morbidity due to prematurity, congenital anomalies (which occur in 6% of all breech presentations), and birth trauma and/or asphyxia. Vaginal Breech Delivery Chapter 12 – Page 1 FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM External Cephalic Version External cephalic version (ECV) is a procedure in which a fetus is turned in utero by manipulation of the maternal abdomen from a non-cephalic to cephalic presentation. Diagnosis of non-vertex presentation Performing Leopold’s manoeuvres during each third trimester prenatal visit should enable the health care provider to make diagnosis in the majority of cases.
    [Show full text]
  • O'brien, SM, Winter, C., Burden, CA, Boulvain, M., Draycott, TJ
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Explore Bristol Research O'Brien, S. M. , Winter, C., Burden, C. A., Boulvain, M., Draycott, T. J., & Crofts, J. F. (2017). Pressure and traction on a model fetal head and neck associated with the use of forceps, Kiwi™ ventouse and the BD Odon Device™ in operative vaginal birth: a simulation study. BJOG: An International Journal of Obstetrics and Gynaecology, 124(S4), 19-25. https://doi.org/10.1111/1471-0528.14760 Peer reviewed version License (if available): CC BY-NC Link to published version (if available): 10.1111/1471-0528.14760 Link to publication record in Explore Bristol Research PDF-document This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Wiley at http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14760/abstract. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms Pressure and traction on a model fetal head and neck associated with the use of forceps, Kiwi™ ventouse and the BD Odon Device™ in operative vaginal birth: a simulation study Authors Stephen M O’Brien a, b, Cathy Winter a, Christy A Burden a, b, Michel Boulvain d, Tim J Draycott a, c, Joanna F Crofts a, c a Department of Obstetrics
    [Show full text]
  • Symphysiotomy for Obstructed Labour
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Birmingham Research Portal Symphysiotomy for obstructed labour: a systematic review and meta-analysis Wilson, Amie; Truchanowicz, Ewa; Elmoghazy, Diaa; MacArthur, Christine; Coomarasamy, Aravinthan DOI: 10.1111/1471-0528.14040 License: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Document Version Peer reviewed version Citation for published version (Harvard): Wilson, A, Truchanowicz, E, Elmoghazy, D, MacArthur, C & Coomarasamy, A 2016, 'Symphysiotomy for obstructed labour: a systematic review and meta-analysis', BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.14040 Link to publication on Research at Birmingham portal Publisher Rights Statement: Checked for eligibility: 06/05/2016 General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • The Identification and Validation of Neural Tube Defects in the General Practice Research Database
    THE IDENTIFICATION AND VALIDATION OF NEURAL TUBE DEFECTS IN THE GENERAL PRACTICE RESEARCH DATABASE Scott T. Devine A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the School of Public Health (Epidemiology). Chapel Hill 2007 Approved by Advisor: Suzanne West Reader: Elizabeth Andrews Reader: Patricia Tennis Reader: John Thorp Reader: Andrew Olshan © 2007 Scott T Devine ALL RIGHTS RESERVED - ii- ABSTRACT Scott T. Devine The Identification And Validation Of Neural Tube Defects In The General Practice Research Database (Under the direction of Dr. Suzanne West) Background: Our objectives were to develop an algorithm for the identification of pregnancies in the General Practice Research Database (GPRD) that could be used to study birth outcomes and pregnancy and to determine if the GPRD could be used to identify cases of neural tube defects (NTDs). Methods: We constructed a pregnancy identification algorithm to identify pregnancies in 15 to 45 year old women between January 1, 1987 and September 14, 2004. The algorithm was evaluated for accuracy through a series of alternate analyses and reviews of electronic records. We then created electronic case definitions of anencephaly, encephalocele, meningocele and spina bifida and used them to identify potential NTD cases. We validated cases by querying general practitioners (GPs) via questionnaire. Results: We analyzed 98,922,326 records from 980,474 individuals and identified 255,400 women who had a total of 374,878 pregnancies. There were 271,613 full-term live births, 2,106 pre- or post-term births, 1,191 multi-fetus deliveries, 55,614 spontaneous abortions or miscarriages, 43,264 elective terminations, 7 stillbirths in combination with a live birth, and 1,083 stillbirths or fetal deaths.
    [Show full text]
  • Presumptive Fertility and Fetoconsciousness: the Ideological Formation of ‘The Female Patient of Reproductive Age’
    PRESUMPTIVE FERTILITY AND FETOCONSCIOUSNESS: THE IDEOLOGICAL FORMATION OF ‘THE FEMALE PATIENT OF REPRODUCTIVE AGE’ A Thesis Submitted to the Temple University Graduate Board In Partial Fulfillment of the Requirements for the Degree MASTER OF ARTS by Emily S. Kirchner May 2017 Thesis Approvals: Nora L. Jones, PhD, Thesis Advisor, Center for Bioethics, Urban Health, and Policy i ABSTRACT Presumptive fertility is an ideology that leads us to treat not only pregnant women, but all female patients of reproductive age, with the presumption that they could be pregnant. This preoccupation with the possibility that a woman could be pregnant compels medical and social interventions that have adverse consequences on women’s lived experiences. It is important to pause now to examine this ideology. Despite our social realities -- there is a patient centered care movement in medical practice, American women are delaying and forgoing childbearing, abortion is safe and legal -- there is still a powerful medical and social process that subjugates womens’ bodies and lived experiences to their potential of being a mother. Fetoconsciousness, preoccupation with the fetus or hypothetical, not-yet-conceived, fetus privileges its potential embodiment over its mother’s reality. As a set of values that influence our beliefs, attitudes, and behaviors, the ideology of presumptive fertility is contextualized, critiqued, and challenged. ii TABLE OF CONTENTS ABSTRACT………………………………………………………………………………ii CHAPTER 1: INTRODUCTION…….….……………...……………………………...…1 CHAPTER 2: TRACING
    [Show full text]
  • |||FREE||| Obstetrics and Gynecology
    OBSTETRICS AND GYNECOLOGY FREE DOWNLOAD Charles R. B. Beckmann,William N.P. Herbert,Douglas W. Laube,Frank Ling,Roger P. Smith | 528 pages | 21 Mar 2013 | Lippincott Williams and Wilkins | 9781451144314 | English | Philadelphia, United States Register for a free account We are grateful for the outstanding care she has provided to our patients. Connect with us on social media! August Learn how and when to remove this template message. Read more. Our providers recommend these 6 helpful tips for reducing your period pain. I haven't seen someone like that in a long time and it was such a Obstetrics and Gynecology surprise. Call us or email us with any questions or to schedule your visit. Chorionic villus sampling Amniocentesis Triple test Quad test Fetoscopy Fetal scalp blood testing Fetal scalp stimulation test Percutaneous umbilical cord blood sampling Apt test Kleihauer—Betke test Lung maturity Lecithin—sphingomyelin ratio Lamellar body count Fetal fibronectin test. Get Obstetrics and Gynecology touch. Wellness and Integrative Care. From pre-conception Now Accepting New Patients Schedule an appointment today. I was in and out in the shortest time possible. Some procedures may include: [8]. Your Partner For a Lifetime of Care. Experienced OB-GYN professionals can seek certifications in sub-specialty areas, including maternal and fetal medicine. You can rest easy knowing that one of our physicians is always on call, 24 hours a day, to deliver your baby. Are you accepting new patients? Imaging Obstetric ultrasonography Nuchal scan Anomaly scan Fetal movement counting Contraction stress test Nonstress test Vibroacoustic stimulation Biophysical profile Amniotic fluid index Umbilical artery dopplers.
    [Show full text]
  • Pretest Obstetrics and Gynecology
    Obstetrics and Gynecology PreTestTM Self-Assessment and Review Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the prod- uct information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. Obstetrics and Gynecology PreTestTM Self-Assessment and Review Twelfth Edition Karen M. Schneider, MD Associate Professor Department of Obstetrics, Gynecology, and Reproductive Sciences University of Texas Houston Medical School Houston, Texas Stephen K. Patrick, MD Residency Program Director Obstetrics and Gynecology The Methodist Health System Dallas Dallas, Texas New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2009 by The McGraw-Hill Companies, Inc.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]